New Deputy Convenor, Australia & Asia-Pacific Clinical Oncology Research and Development (ACORD) Workshop
30 September 2025
Dr Jia (Jenny) Liu appointed as Deputy Convenor of the Australia & Asia-Pacific Clinical Oncology Research Development (ACORD) Workshop
The Medical Oncology Group Australia (MOGA) is pleased to announce that Dr Jia (Jenny) Liu* has been appointed as the Deputy Convenor of the ACORD Workshop and program. Dr Liu will serve as the Deputy Convenor and a key Faculty for the 2026 ACORD Workshop (20-25 September, Novotel, Sydney Olympic Park) and then transition to Project lead. MOGA received several strong applications for this important leadership role within the Australian medical oncology profession, from experienced ACORD Alumni and Faculty members, that testify to the strength of the program and its future capacity.
This appointment which commences from 1 October recognises Dr Liu’s proven leadership in oncology clinical practice, education, research and clinical trials, in addition to her contributions to the ACORD program. Dr Liu is a valued member of the MOGA Executive who established and leads the National Mentorship Program; and, as the Executive Lead on the ACORD sub-committee has been proactively advocating for increased funding and international support to ensure the future viability of this important educational initiative.
Dr Jia (Jenny) Liu | Professional Biography
Dr Jia (Jenny) Liu (MD PhD FRACP) is a medical oncology staff specialist at The Kinghorn Cancer Centre, St Vincent’s Hospital (Darlinghurst, Sydney) specialising in head and neck cancer and early phase clinical trials. She is the translational lead of the early phase trials unit and supervises biomarker-directed trials including several investigator-initiated trials, with close collaborations with scientists at the Garvan Institute and ProCan Children’s Medical Research Institute, Westmead.
She graduated from UNSW with BMed MD with the University Medal and completed her PhD in 2011 on colorectal cancer epigenetics. She has maintained an active research portfolio concurrent to full time clinical training over the past decade.
She is a honorary researcher at the Garvan Institute and visiting scientist at the Children’s Medical Oncology (ProCan) group, where she is liaising with collaborators nationally and internationally to utilise a novel high throughput mass spectromety pipeline which accurately measures tumour tissue proteomes to identify signatures associated with treatment response and outcome in multiple cancer cohorts. She has active research interests in supportive care including the development of novel interventions to address fear of cancer research in cancer survivors, and translational research to identify biomarkers to improve treatment prediction and prognostication.
acord 2026 workshop
Date: Sunday, 20 September - Friday, 25 September 2025
Venue: Novotel Sydney Olympic Park
Co-convenors: A/Prof Katrin Sjoquist and Dr Jia (Jenny) Liu
Dr Jia (Jenny) Liu